Joseph S. McCracken - Jun 5, 2024 Form 4 Insider Report for LUMOS PHARMA, INC. ((LUMO))

Role
Director
Signature
/s/ Ryan Trytten, attorney-in-fact
Stock symbol
(LUMO)
Transactions as of
Jun 5, 2024
Transactions value $
$0
Form type
4
Date filed
6/7/2024, 04:07 PM
Previous filing
Dec 15, 2023
Next filing
Nov 20, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2009 Equity Incentive Plan (the "Plan"). One hundred percent (100%) of the shares shall vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date. The option expires ten years after the date of grant.